Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.

Cancer genomics & proteomics - 1 Jan 2000

Híveš Márk, Jurečeková Jana, Kliment Ján, Grendár Marián, Kaplán Peter, Dušenka Róbert, Evin Daniel, Vilčková Marta, Holečková Klaudia Híveš, Sivoňová Monika Kmeťová

Abstract excerpt

BACKGROUND/AIM: Our aim was to investigate possible influences of genetic variants in genes involved in the G1/S transition [cyclin-dependent kinase-2 (CDK2), cyclin E1 (CCNE1) and cyclin-dependent kinase inhibitor 1B (p27KIP1)] on the expression/activity of their corresponding proteins and to assess the functional impact of these variants on the risk of prostate cancer. MATERIALS AND METHODS: We genotyped 530...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Cycle Proteins
Share to Cyclin-Dependent Kinase 2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclin-Dependent Kinase Inhibitor p27

Share to Cyclin E

Share to Genetic Variation

Share to Oncogene Proteins

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 35430569
DOI: 10.21873/cgp.20326
PMCID: PMC9016479

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Role of Genetic Variations in CDK2, CCNE1 and p27KIP1 in Prostate Cancer.PMID 35430569Read ↗

Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.Semantic proximity Read ↗

Genetic variants in cell cycle control pathway confer susceptibility to aggressive prostate carcinoma.Semantic proximity Read ↗

CDKN1A and CDKN1B polymorphisms and risk of advanced prostate carcinoma.Semantic proximity Read ↗

Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.Semantic proximity Read ↗

Association of EGLN2 rs10680577 Polymorphism with the Risk and Clinicopathological Features of Patients with Prostate Cancer.Semantic proximity Read ↗

Are cell cycle and apoptosis genes associated with prostate cancer risk in North Indian population?Semantic proximity Read ↗

Genetic variants in RNA-induced silencing complex genes and prostate cancer.Semantic proximity Read ↗

A polymorphism in the CDKN1B gene is associated with increased risk of hereditary prostate cancer.Semantic proximity Read ↗

[Single nucleotide polymorphisms of CYP1A2 and their correlation with prostate cancer].Semantic proximity Read ↗

Transcription Factor KLF5 Binds a Cyclin E1 Polymorphic Intronic Enhancer to Confer Increased Bladder Cancer Risk.Semantic proximity Read ↗

Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.